Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Regulation of metformin response by breast cancer associated gene 2.

Buac D, Kona FR, Seth AK, Dou QP.

Neoplasia. 2013 Dec;15(12):1379-90.


From bortezomib to other inhibitors of the proteasome and beyond.

Buac D, Shen M, Schmitt S, Kona FR, Deshmukh R, Zhang Z, Neslund-Dudas C, Mitra B, Dou QP.

Curr Pharm Des. 2013;19(22):4025-38. Review.


Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.

Buac D, Schmitt S, Ventro G, Kona FR, Dou QP.

Mini Rev Med Chem. 2012 Oct;12(12):1193-201.


Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.

Kona FR, Stark K, Bisoski L, Buac D, Cui Q, Dou QP.

Breast Cancer Res Treat. 2012 Sep;135(2):495-503. doi: 10.1007/s10549-012-2107-4. Epub 2012 Aug 1.


Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.

Brahemi G, Kona FR, Fiasella A, Buac D, Soukupov√° J, Brancale A, Burger AM, Westwell AD.

J Med Chem. 2010 Apr 8;53(7):2757-65. doi: 10.1021/jm901757t.

Supplemental Content

Support Center